Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | KZIA | MBRX | ||
| Company | Adaptimmune Ther ADR | Kazia Therapeutics Ltd ADR | Moleculin Biotech CS | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0666 | 8.82 | 2.72 | ||
| High | 0.0701 | 10.18 | 2.72 | ||
| Low | 0.0526 | 8.82 | 2.45 | ||
| Latest | 0.0549 | 9.30 | 2.45 | ||
| Change | -0.0098 | +0.31 | -0.27 | ||
| % Change | -15.15% | +3.39% | -9.93% | ||
| Volume | 50,777,800 | 311,854 | 131,042 | ||
| 20-Day Average Volume | 127,153,055 | 155,411 | 91,708 | ||
| Previous Close | 0.0647 | 8.99 | 2.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1355 | 7.90 | 2.33 | ||
| 20-Day Raw Stochastic | 5.66% | 74.40% | 60.00% | ||
| 20-Day Relative Strength | 40.90 | 59.93 | 44.90 | ||
| Weighted Alpha | -58.21 | +23.63 | -64.85 | ||
| Today's Opinion | 88% Sell | 24% Buy | 80% Sell | ||
| Previous Opinion | 88% Sell | 24% Buy | 80% Sell | ||
| Last Month's Opinion | 56% Sell | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.95% since 10/20/25 | -3.12% since 04/07/26 | +1.66% since 04/07/26 | ||
| Low | 0.0417 on 10/21/25 | 8.41 on 04/10/26 | 2.41 on 04/08/26 | ||
| High | 0.0926 on 10/22/25 | 10.18 on 04/14/26 | 2.77 on 04/13/26 | ||
| 1-Month | |||||
| %Chg | -62.65% since 09/26/25 | +24.43% since 03/13/26 | +20.10% since 03/13/26 | ||
| Low | 0.0417 on 10/21/25 | 6.82 on 03/24/26 | 1.97 on 03/19/26 | ||
| High | 0.2750 on 10/09/25 | 10.18 on 04/14/26 | 2.77 on 04/13/26 | ||
| 3-Month | |||||
| %Chg | -84.17% since 07/25/25 | +36.26% since 01/14/26 | -40.82% since 01/14/26 | ||
| Low | 0.0403 on 09/08/25 | 4.86 on 02/12/26 | 1.79 on 03/09/26 | ||
| High | 0.2750 on 10/09/25 | 10.49 on 03/03/26 | 5.30 on 02/18/26 | ||
| 6-Month | |||||
| %Chg | -79.31% since 04/25/25 | +33.52% since 10/14/25 | -80.20% since 10/14/25 | ||
| Low | 0.0403 on 09/08/25 | 4.86 on 02/12/26 | 1.79 on 03/09/26 | ||
| High | 0.3578 on 07/24/25 | 17.40 on 12/08/25 | 15.75 on 11/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,551 | 14,864 | 14,515 | ||
| Shares Outstanding, K | 265,052 | 1,653 | 5,336 | ||
| Annual Sales | 178,030,000 | 1,230,000 | 0 | ||
| Annual Net Income | -70,810,000 | -13,410,000 | -33,560,000 | ||
| Last Quarter Sales | 13,680,000 | 2,897,743 | 0 | ||
| Last Quarter Net Income | -30,340,000 | -4,369,673 | 5,910,000 | ||
| 60-Month Beta | 2.49 | 1.61 | 1.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/13/25 | N/A | -3.25 on 11/13/25 | ||
| Latest Earnings Date | 11/12/25 | 02/06/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||